These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34055189)

  • 1. Once-daily Dapsone 7.5% Gel for the Treatment of Acne Vulgaris in Preadolescent Patients: A Phase IV, Open-label, 12-week Study.
    Moore AY; Lain EL; McMichael A; Kircik L; Zaenglein AL; Hebert AA; Grada A
    J Clin Aesthet Dermatol; 2021 Apr; 14(4):43-48. PubMed ID: 34055189
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy, Safety, and Dermal Tolerability of Dapsone Gel, 7.5% in Patients with Moderate Acne Vulgaris: A Pooled Analysis of Two Phase 3 Trials.
    Thiboutot DM; Kircik L; McMichael A; Cook-Bolden FE; Tyring SK; Berk DR; Chang-Lin JE; Lin V; Kaoukhov A
    J Clin Aesthet Dermatol; 2016 Oct; 9(10):18-27. PubMed ID: 27847545
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: First of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-controlled Trials.
    Stein Gold LF; Jarratt MT; Bucko AD; Grekin SK; Berlin JM; Bukhalo M; Weiss JS; Berk DR; Chang-Lin JE; Lin V; Kaoukhov A
    J Drugs Dermatol; 2016 May; 15(5):553-61. PubMed ID: 27168264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: Second of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-Controlled Trials.
    Eichenfield LF; Lain T; Frankel EH; Jones TM; Chang-Lin JE; Berk DR; Ruan S; Kaoukhov A
    J Drugs Dermatol; 2016 Aug; 15(8):962-9. PubMed ID: 27537997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, Safety, and Tolerability of Topical Dapsone Gel, 7.5% for Treatment of Acne Vulgaris by Fitzpatrick Skin Phototype.
    Taylor SC; Cook-Bolden FE; McMichael A; Downie JB; Rodriguez DA; Alexis AF; Callender VD; Alvandi N
    J Drugs Dermatol; 2018 Feb; 17(2):160-167. PubMed ID: 29462223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-Daily Topical Dapsone Gel, 7.5%: Effective for Acne Vulgaris Regardless of Baseline Lesion Count, With Superior Efficacy in Females.
    Tanghetti E; Harper J; Baldwin H; Kircik L; Bai Z; Alvandi N
    J Drugs Dermatol; 2018 Nov; 17(11):1192-1198. PubMed ID: 30500141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-Daily Topical Dapsone Gel, 7.5%: Effective for Acne Vulgaris Regardless of Baseline Lesion Count, With Superior Efficacy in Females.
    Tanghetti E; Harper J; Baldwin H; Kircik L; Bai Z; Alvandi N
    J Drugs Dermatol; 2018 Nov; 17(11):1192-1198. PubMed ID: 30500140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-Daily Topical Dapsone Gel, 7.5%: Effective for Acne Vulgaris Regardless of Baseline Lesion Count, With Superior Efficacy in Females.
    Tanghetti E; Harper J; Baldwin H; Kircik L; Bai Z; Alvandi N
    J Drugs Dermatol; 2018 Nov; 17(11):1192-1198. PubMed ID: 30500139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Efficacy and Safety of Topical Dapsone Gel, 5% for the Treatment of Acne Vulgaris in Adult Females With Skin of Color.
    Alexis AF; Burgess C; Callender VD; Herzog JL; Roberts WE; Schweiger ES; Stockton TC; Gallagher CJ
    J Drugs Dermatol; 2016 Feb; 15(2):197-204. PubMed ID: 26885788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Pharmacokinetics of Once-Daily Dapsone Gel, 7.5% in Patients With Moderate Acne Vulgaris.
    Jarratt MT; Jones TM; Chang-Lin JE; Tong W; Berk DR; Lin V; Kaoukhov A
    J Drugs Dermatol; 2016 Oct; 15(10):1250-1259. PubMed ID: 27741344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of dapsone gel, 5% for the treatment of acne vulgaris.
    Thiboutot DM; Willmer J; Sharata H; Halder R; Garrett S
    Clin Pharmacokinet; 2007; 46(8):697-712. PubMed ID: 17655376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate and Severe Acne Vulgaris in Females: Effect of Age on Efficacy and Tolerability.
    Stein Gold L; Pariser DM; Guenin E
    J Drugs Dermatol; 2019 Dec; 18(12):1218-1225. PubMed ID: 31860209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy and tolerability of dapsone 5% gel in adult versus adolescent females with acne vulgaris.
    Del Rosso JQ; Kircik L; Gallagher CJ
    J Clin Aesthet Dermatol; 2015 Jan; 8(1):31-7. PubMed ID: 25610522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Truncal Acne Vulgaris with Topical Dapsone 7.5% Gel.
    Del Rosso JQ; Kircik L; Tanghetti E
    J Clin Aesthet Dermatol; 2018 Aug; 11(8):45-50. PubMed ID: 30214667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Dapsone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Dapsone 5% Gel Combination Treatment.
    Kircik LH
    J Drugs Dermatol; 2016 Feb; 15(2):191-5. PubMed ID: 26885787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris.
    Tanghetti E; Dhawan S; Green L; Ling M; Downie J; Germain MA; Kasteler JS; Kircik L; Oefelein MG; Draelos Z
    J Drugs Dermatol; 2011 Jul; 10(7):783-92. PubMed ID: 21720661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Open-label Study to Investigate the Efficacy and Tolerability of Dapsone Gel, 7.5% in the Treatment of Acne Vulgaris in Men and Women With Skin of Color.
    El-Kashlan N; Cices A; Kaufman B; Da Rosa JC; Sanabria-Gonzalez I; Khattri S; Alexis A
    J Drugs Dermatol; 2024 Jun; 23(6):410-417. PubMed ID: 38834229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris.
    Draelos ZD; Carter E; Maloney JM; Elewski B; Poulin Y; Lynde C; Garrett S;
    J Am Acad Dermatol; 2007 Mar; 56(3):439.e1-10. PubMed ID: 17208334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Experience With Once-Daily Dapsone Gel, 7.5% Monotherapy in Patients With Acne Vulgaris.
    Stockton TC; Tanghetti EA; Lain E; Zeichner JA; Alvandi N
    J Drugs Dermatol; 2018 Jun; 17(6):602-608. PubMed ID: 29879247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dapsone 7.5% Gel: A Review in Acne Vulgaris.
    Al-Salama ZT; Deeks ED
    Am J Clin Dermatol; 2017 Feb; 18(1):139-145. PubMed ID: 28005194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.